US FDA seeks feedback to draft guidelines on product classification
This article was originally published in Clinica
Executive Summary
The US FDA has issued for public consultation two related draft guidelines on product classification issues including classifying medical products as drugs or devices and interpreting the term "chemical action" in the context of medical devices.
You may also be interested in...
FDA Final Guidance On Drug/Device Classifications Misses The Mark, Attorneys Say
The final guidance adds some requested clarifications, but does not appear to address the US agency's tendency to designate products as drugs over devices, industry attorneys argue.
Combo Product Classification Guidance Doesn't Fix All Existing Problems, Experts Say
US FDA's tendency to designate products as drugs over devices may remain despite clarifications offered in final guidance.
Hunt On For New Chair Of UK Regulator
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: